TROP2:

Keiko Tanegashima1, Yuka Tanaka1, Takamichi Ito1

  • 1Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Experimental dermatology
|October 18, 2024
PubMed
概括

热囊细胞表面抗原2 (TROP2) 对皮肤状细胞癌 (cSCC) 的生长和迁移至关重要. 用sacituzumab govitecan针对TROP2的向显示了治疗晚期cSCC的前景.